HPV-16 and HPV-18 L1 capsid proteins — Drug Target

All drugs that target HPV-16 and HPV-18 L1 capsid proteins — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Prophylactic vaccine

Phase 3 pipeline (1)

• HPV-16/18 vaccine · Shanghai Zerun Biotechnology Co.,Ltd · Prophylactic vaccine · Oncology / Immunology
  This vaccine stimulates the immune system to produce antibodies and cellular immunity against human papillomavirus types 16 and 18, preventing infection and associated cancers.